US 10260069
Selective antisense compounds and uses thereof
granted A61PA61P25/00
Quick answer
US patent 10260069 (Selective antisense compounds and uses thereof) held by Ionis Pharmaceuticals, Inc. expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P25/00